Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Two-Stage Trial of the Safety, Pharmacodynamics, Biodistribution, Immunogenicity and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A

NCT06185335 is registered in ClinicalTrials.gov with Biocad as lead sponsor.

NCT NCT06185335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06185335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Two-Stage Trial of the Safety, Pharmacodynamics, Biodistribution, Immunogenicity and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A
Lead sponsor
Biocad
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
July 26, 2023
Completion date
June 30, 2033
Enrollment
50 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a